Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study - PubMed (original) (raw)

Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study

Thang S Han et al. Obes Res. 2002 Sep.

Free article

Abstract

Objective: To use standardized cut-offs of body mass index (BMI), waist circumference, waist-to-hip ratio, and fasting insulin levels to predict the development of metabolic disorders and metabolic syndrome.

Research methods and procedures: We performed an 8-year follow-up study of 628 non-Hispanic whites and 1340 Mexican Americans, ages 25 to 64 years, from the second cohort of the San Antonio Heart Study. We defined metabolic disorders as dyslipidemia (triglycerides > or =2.26 mM or high-density lipoprotein <0.91 mM in men and <1.17 mM in women), hypertension (blood pressure > or =140 or >=90 mm Hg, or receiving antihypertensive medications), and type 2 diabetes (fasting glucose > or =7.0 mM, 2-hour test glucose > or =11.1 mM, or receiving anti-diabetic medications). People with at least two metabolic disorders were defined as having metabolic syndrome.

Results: High waist-to-hip ratio and fasting insulin levels were significant predictors of developing metabolic syndrome. High anthropometric indices remained significant predictors of metabolic syndrome after adjusting for fasting insulin. Waist circumference, BMI, and insulin had similar areas under the receiver operating characteristic curves (0.74 to 0.76). Further multivariate analyses combining these indices showed minimal increase in prediction. Of subjects who had a combination of high BMI (> or =30 kg/m(2)) and high waist circumference (above "Action Level 2"), 32% developed metabolic syndrome, compared with 10% of subjects with both low BMI and low waist circumference.

Discussion: These findings support the National Institutes of Health recommendations for reducing the risk of metabolic syndrome. Adjustment for baseline fasting insulin levels had only a small effect on the ability of anthropometric indices to predict the metabolic syndrome.

PubMed Disclaimer

Cited by

Comparison of Metabolic Syndrome, Autoimmune and Viral Distinctive Inflammatory Related Conditions as Affected by Body Mass Index.
Chero-Sandoval L, Martínez-Urbistondo M, Cuevas-Sierra A, Higuera-Gómez A, Martin-Domenech E, Castejón R, Mellor-Pita S, Moreno-Torres V, Ramos-Lopez O, de Luis D, Vargas JA, Martínez JA. Chero-Sandoval L, et al. J Clin Med. 2024 Oct 22;13(21):6298. doi: 10.3390/jcm13216298. J Clin Med. 2024. PMID: 39518437 Free PMC article.
Effects of Daily Intake of Rosehip Extract on Low-Density Lipoprotein Cholesterol and Blood Glucose Levels: A Systematic Review.
Belkhelladi M. Belkhelladi M. Cureus. 2023 Dec 28;15(12):e51225. doi: 10.7759/cureus.51225. eCollection 2023 Dec. Cureus. 2023. PMID: 38283449 Free PMC article. Review.
Employing broad learning and non-invasive risk factor to improve the early diagnosis of metabolic syndrome.
Duan J, Wang Y, Chen L, Chen CLP, Zhang R. Duan J, et al. iScience. 2023 Dec 5;27(1):108644. doi: 10.1016/j.isci.2023.108644. eCollection 2024 Jan 19. iScience. 2023. PMID: 38188510 Free PMC article.
The Prevalence and Trend of Metabolic Syndrome in the South-East of Iran.
Farmanfarma KK, Kaykhaei MA, Mohammadi M, Adineh HA, Ansari-Moghaddam A. Farmanfarma KK, et al. J Med Life. 2020 Oct-Dec;13(4):587-599. doi: 10.25122/jml-2020-0052. J Med Life. 2020. PMID: 33456611 Free PMC article.
Relationship between the optimal cut-off values of anthropometric indices for predicting metabolic syndrome and carotid intima-medial thickness in a Korean population.
Yang YJ, Park HJ, Won KB, Chang HJ, Park GM, Kim YG, Ann SH, Park EJ, Kim SJ, Lee SG. Yang YJ, et al. Medicine (Baltimore). 2019 Oct;98(42):e17620. doi: 10.1097/MD.0000000000017620. Medicine (Baltimore). 2019. PMID: 31626142 Free PMC article.

Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study - PubMed (original) (raw)